Respiratory System Pathologies

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/62

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

63 Terms

1
New cards

Sympathetic Nervous System (bronchodilation and constriction)

Activates beta 2 receptors which causes relaxation of bronchial smooth muscle, causing dilation

2
New cards

Parasympathetic Nervous System (Bronchodilation and constriction)

Causes contraction of bronchial smooth muscle, resulting in narrowing of the airway, known as constriction. 

3
New cards

Bronchodilators

Drugs that activate beta 2 receptors

4
New cards

Bronchoconstriction 

These drugs result in shortness of breath and labored breathing. 

5
New cards

Upper respiratory Disorders

Impacts the nose, paranasal sinuses, pharynx, larynx, and trachea. result of an allergic reaction to an allergen and an antibody response to an antigen (i.e., virus). 

6
New cards

Treatment for Upper respiratory Disorders

Treatment includes decreasing the allergic response, supportive care, or antibiotics. 

7
New cards

Lower respiratory disorders

Impacts the lungs, bronchi, and alveoli- infectious vs noninfectious. A result of bronchial hypersensitivity. Results in inflammation and decreased airflow.

8
New cards

Lower respiratory disorders treatment

Includes decreasing inflammation and restoring airflow through dilation and treating cause. 

9
New cards

Lower respiratory chronic conditions

COPD, Asthma, Emphysema, Chronic Bronchitis, Cystic Fibrosis

10
New cards

Lower respiratory Acute infectious

Bronchiolitis, Acute Bronchitis, Pneumonia

11
New cards

Chronic inflammatory disorder of airways (ASTHMA)

Recurrent episodes of reversible airway obstruction, hyperreactive airways, incidence greatest in industrialized countries. 

12
New cards

Acute inflammatory response

Stimulates the secretion of histamine and other inflammatory mediators 

13
New cards

Bronchoconstriction

narrows the airway in response to a triggering agent. 

14
New cards

Triggers for asthma

Allergies, infections, exercise, and medications.

15
New cards

Asthma etiology

Unkown etiology

16
New cards

Classification considerations for Asthma

Clinical presentations, precipitating factors or triggers, and allergies. 

17
New cards

Risk factors for Asthma

Genetics, History, Gender, Obesity, Exposure to allergens, irritants, and tobacco smoke. 

18
New cards

Allergic Asthma (most common)

An allergen causes a type 1 hypersensitivity response.

19
New cards

Recurrent Asthma

Airways are remodeled, bronchial smooth muscles hypertrophy, increasing the capacity for bronchoconstriction.

20
New cards

Status ashamticus

The term for a severe, prolonged form of asthma that is unresponsive to drug treatment and may result in respiratory failure. (Always have an inhaler ready!)

21
New cards

Asthma Clinical Manifestations

Recurrent chest tightness, shortness of breath, wheezing, cough with or without production of thick sputum, severe episodes, tachypnea, and tachycardia.

22
New cards

Severity classifications of Asthma

Mild intermittent asthma, mild, moderate, or severe persistent asthma. 

23
New cards

Diagnosis Asthma

Medical history and physical examination, PFTs before and after bronchodilator use, challenge test, and exhaled nitrogen oxide.

24
New cards

Treatment for asthma

environmental control, asthma education.

25
New cards

Two goals of therapy

To terminate acute bronchospasms in progress with quick-relief medications AND to reduce the frequency of asthma attacks with long-acting meds.

26
New cards

Bronchodilators should always be administered before anti-inflammatory meds

Priority is to open bronchioles.

27
New cards

Quick-relief meds

Beta 2 adrenergic agonists, anticholinergics, systemic corticosteroids.

28
New cards

Long-acting meds

Inhaled corticosteroids, leukotriene modifiers, long-acting beta 2 adrenergic agonists, methylxanthines, and immunomodulators. 

29
New cards

Management of ASTHMA

A- Adrenergics (Beta 2 Agonists) (Albuterol), S- Steroids

T- Theophylline

H- Hydration (IV)

M- Mask O2

A- Anticholinergics  (A lot of mucous production)

30
New cards

Chronic Obstructive Pulmonary Disease (COPD)

Progressive airflow limitations that are not fully reversible. Includes chronic bronchitis and emphysema. Linked to cigarette smoking. Gradual onset with slowly progressive symptoms of dyspnea and shortness of breath (SOB). 

31
New cards

COPD Risk Factors

Direct and environmental tobacco smoke, genetics, occupational exposure, indoor air pollution, severe respiratory infections. 

32
New cards

COPD Etiology

Chronic airflow limitation due to abnormal inflammatory response to inhaled particles and gases in the lung. 

33
New cards

COPD mild

mild airflow limitation, possible chronic cough and sputum production, possible unawareness of the individual that lung function is abnormal. 

34
New cards

COPD Moderate

Worsening airflow limitations, SOB on exertion, possible cough and sputum production, and chronic respiratory symptoms lead person to seeking care. 

35
New cards

COPD Severe

Further worsening of airflow limitations, greater SOB. Reduced exercise capacity, fatigue, and repeated exacerbations. An affect on patients quality of life. 

36
New cards

COPD Very severe

Severe airflow limitations plus chronic respiratory failure.

37
New cards

COPD Pathophysiology

Airway obstruction occurs when fixed airways have increased resistance, slowing the rate of airflow. chronic inflammation, structural remodeling of lung tissue, alterations in vascular structure, and destruction of pulmonary structures. Hypercapnia, hyperinflation. 

38
New cards

Chronic Bronchitis

Fixed airway obstruction caused by scarring that thickens the basement membranes. Increased number and size of mucus glands. Loss of support for small airways. persistent, inflammation-induced narrowing of airways. Symptoms: copious mucus production (causes a mucus plug), chronic productive cough. 

39
New cards

Emphysema 

Damage to the lung parenchyma, destruction of the gas-exchanging pulmonary surfaces. pulmonary hyperinflation. cigarette smoking (primary).

40
New cards

Chronic bronchitis (charactersisitcs)

Productive cough for three months in two consecutive years. Progressively worsening dyspnea with SOB and dyspnea on exertion (DOE)

41
New cards

Emphysema (characterstics)

Increased DOE, Barrel chest, respiratory muscles, hypoxemia, foot and ankle swelling, 

42
New cards

Advanced COPD

-Reduced capacity for gas exchange, deterioration of pulmonary function. 

43
New cards

Early Hypoxia

Restlessness, anxiety, low vs

44
New cards

COPD Diagnosis

PFTs, Spirometry, Body plethysmography. X-ray

45
New cards

COPD Treatment

Assessment and monitoring, reducing risk factors, managing stable COPD, managing acute exacerbations

46
New cards

Cystic Fibrosis

The most common lethal genetic disorder. Reabsorption of sodium is enhanced in epithelial exocrine cells. lifelong morbidity. 

47
New cards

Cystic Fibrosis Pathophysiology

A recessive genetic disorder, affects epithelial transport of fluids. 

48
New cards

Cystic Fibrosis Clinical manifestations

Thick pulmonary secretions, frequent respiratory infections, chronic cough, abdominal distention, large, fatty, foul-smelling stools. 

49
New cards

Cystic Fibrosis Diagnosis

Skin Sweat Test

50
New cards

Cystic Fibrosis Treatment

Antibiotics for secondary infections, vitamin supplements, and pancreatic digestive enzyme replacement.

51
New cards

Infectious diseases of the lower respiratory tract: clinical manifestations

Cough, malaise, fever, sore, inflamed throat, enlarged lymph nodes, mucoid or purulent sputum, wheezing, fine crackles on auscultation (CHF will hear crackles).

52
New cards

Acute Bronchitis infectious causes

Bacteria and viruses

53
New cards

Acute Bronchitis Noninfectious triggers

Asthma, air pollutants, inhaling irritating substances. 

54
New cards

Clinical manifestations for acute bronchitis

Bronchial inflammation with mucosal congestion and cough. Sore throat with hoarseness, dyspnea, chest pain, and myalgias (lack of energy). Differentiated from pneumonia by chest x-ray. 

55
New cards

Bronchiolitis clinical manifestations

Necrosis of the respiratory epithelium, excess mucus production and submucosal swelling. can have both inspiratory and expiratory wheezing. 

56
New cards

Bronchiolitis Treatment

Supportive management of respiratory symptoms.

57
New cards

Pneumonia Characteristics.

Inflammation of the lung parenchyma, lung consolidation with alveoli filled with exudate. major cause of morbidity.

58
New cards

pneumonia causes

Hospital-acquired pneumonia (HAP), Ventilator-associated pneumonia (VAP), Healthcare-associated pneumonia (HCAP). 

59
New cards

Pneumonia Classifications

Location where the patient was exposed to the pathogen. causative pathogen, location of pathogen within the lung. 

60
New cards

Pneumonia Pathogenesis

Opportunistic pneumonia. Zoonotic infections, infections with bioterrorism potential. Bacterial vs viral. 

61
New cards

pneumonia clinical manifestations

Typical: abrupt onset of high fever, chills, productive cough with mucopurulent sputum. Atypiacal: milder symptoms that last longer

62
New cards

Pneumonia diagnosis

X-ray and sputum analyses

63
New cards

Treatment for pneumonia

Supportive measures, supplemental oxygen, antibiotics, and antivirals.